Detalles de la búsqueda
1.
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance : An Analysis From a Population-Based Screening Study.
Ann Intern Med
; 2024 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38768457
2.
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial.
Ann Intern Med
; 177(4): 449-457, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38560901
3.
Prior cancer and risk of monoclonal gammopathy of undetermined significance: a population-based study in Iceland and Sweden.
Haematologica
; 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38205512
4.
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group.
Lancet Oncol
; 24(7): e293-e311, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414019
5.
Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study.
Haematologica
; 108(12): 3392-3398, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37439374
6.
Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group.
Lancet Oncol
; 22(3): e119-e130, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33545067
7.
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.
Lancet Oncol
; 22(3): e105-e118, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33662288
8.
Effect of initial treatment on health-related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect® MM Registry.
Br J Haematol
; 193(1): 93-100, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33118614
9.
Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysis.
Cancer
; 126(19): 4332-4340, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32706404
10.
Daratumumab-lenalidomide-dexamethasone vs standard-of-care regimens: Efficacy in transplant-ineligible untreated myeloma.
Am J Hematol
; 95(12): 1486-1494, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32804408
11.
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders.
Lancet Oncol
; 20(6): e302-e312, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31162104
12.
Development of a prognostic model for overall survival in multiple myeloma using the Connect® MM Patient Registry.
Br J Haematol
; 187(5): 602-614, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31382320
13.
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial.
Lancet
; 389(10068): 519-527, 2017 02 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28017406
14.
Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group.
Blood
; 127(24): 2955-62, 2016 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-27002115
15.
Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry.
Ann Hematol
; 97(12): 2425-2436, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30056582
16.
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.
Lancet Oncol
; 18(4): e206-e217, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28368259
17.
Meaningful endpoints for therapies approved for hematologic malignancies.
Cancer
; 123(10): 1689-1694, 2017 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28222220
18.
Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma.
Blood
; 126(20): 2284-90, 2015 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26384354
19.
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report.
Blood
; 125(13): 2068-74, 2015 03 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-25628469
20.
Observational study of multiple myeloma in Latin America.
Ann Hematol
; 96(1): 65-72, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27815724